Aisling Capital is a leading investment firm that invests in companies developing and commercializing important and innovative healthcare products, services and technologies.

Meet Our Team

A combined 150+ years of experience in the healthcare industry.

learn more

See Our Portfolio

$1.8 billion in assets, with a track record of investing and returning capital since 2000.

learn more

Latest News

Zosano Pharma Announces NDA Resubmission Plans Following Type A Meeting with FDA

February 1, 2021
FREMONT, CA - February 01, 2021 - Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the company completed its Type A meeting with the U.S. Food and…
READ MORE

Poseida Therapeutics Added to Nasdaq Biotechnology Index

December 18, 2020
SAN DIEGO, CA - December 18, 2020 - Poseida Therapeutics, Inc. (NASDAQ: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary gene engineering platform technologies to create cell and gene therapeutics with…
READ MORE

Syndax Pharmaceuticals To Be Added to the NASDAQ Biotechnology Index

December 18, 2020
WALTHAM, MA - December 18, 2020 -  Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that the Company has…
READ MORE